approved

Приложение 4 на ПЛС от 02.06.2020 г.

Unique identificator:  4ae0eb5e-4f0c-4e5f-b918-75e603e96e47

Current version: 1

Displayed version: 1

Format: CSV

  • Created at: 2020-06-11 15:08:08
  • Created by: georgi_sivchev
  • Updated at: 2020-06-11 15:08:08
records per page
Order by:

ПОЗИТИВЕН ЛЕКАРСТВЕН СПИСЪК

Tocilizumab EU/1/08/492/007 RoActemra, Solution for injection, 162, mg, Pack: 4 pre-filled syringes Roche Registration GmbH, Германия Roche Pharma AG - Germany 1600.59 320.12 1920.71 4% 10 1610.59 322.12 1932.71 16% 25 1635.59 327.12 1962.71 Промяна на обстоятелствата НСР-15981/22.06.2018. НСР-6424/12.06.2015.; НСР-13341/28.07.2017; НСР-16870/28.09.2018 13.10.2018 02.11.2018 Неактивен 3260
Tocilizumab EU/1/08/492/007 RoActemra, Solution for injection, 162, mg, Pack: 4 pre-filled syringes Roche Registration GmbH, Германия Roche Pharma AG - Germany 1600.59 320.12 1920.71 4% 10 1610.59 322.12 1932.71 16% 25 1635.59 327.12 1962.71 Промяна на обстоятелствата НСР-15981/22.06.2018. НСР-6424/12.06.2015.; НСР-13341/28.07.2017; НСР-16870/28.09.2018 13.10.2018 02.11.2018 Неактивен 3260
Tocilizumab EU/1/08/ 492/007 RoActemra, Solution for injection, 162, mg, Pack: 4 pre-filled syringes Roche Registration GmbH, Германия Roche Pharma AG - Germany 1600.65 320.13 1920.78 4% 10 1610.65 322.13 1932.78 16% 25 1635.65 327.13 1962.78 Промяна на обстоятелствата НСР-15981/22.06.2018. НСР-6424/12.06.2015.; НСР-13341/28.07.2017 12.08.2017 02.08.2018 Неактивен 3260
Tocilizumab EU/1/08/ 492/007 RoActemra, Solution for injection, 162, mg, Pack: 4 pre-filled syringes Roche Registration Limited, Обединено Кралство Roche Pharma AG - Germany 1600.65 320.13 1920.78 4% 10 1610.65 322.13 1932.78 16% 25 1635.65 327.13 1962.78 НСР-6424/12.06.2015.; НСР-13341/28.07.2017 12.08.2017 02.09.2017 Неактивен 3260
Tocilizumab EU/1/08/ 492/007 RoActemra, Solution for injection, 162, mg, Pack: 4 pre-filled syringes Roche Registration Limited, Обединено Кралство Roche Pharma AG - Germany 1675.6 335.12 2010.72 4% 10 1685.6 337.12 2022.72 16% 25 1710.6 342.12 2052.72 НСР-6424/12.06.2015. 26.06.2015 26.06.2015 Неактивен 3260
Tocilizumab EU/1/08/492/007 RoActemra, Solution for injection, 162, mg, Pack: 4 pre-filled syringes Roche Registration Limited, Обединено Кралство Roche Pharma AG - Germany 1795.86 359.17 2155.03 4% 10 1805.86 361.17 2167.03 16% 25 1830.86 366.17 2197.03 НСР-4826/ 13.10.2014 27.10.2014 27.10.2014 Неактивен 3260
Tocilizumab EU/1/08/4 92/009 RoActemra, Solution for injection, 162, mg, Pack: 4 pre-filled pens Roche Registration GmbH, Германия Roche Pharma AG, Germany 1563.84 312.77 1876.61 4% 10 1573.84 314.77 1888.61 16% 25 1598.84 319.77 1918.61 НСР-16864/28.09.2018; НСР-20222/22.11.2019 Предварително изпълнение 22.11.2019 02.01.2020 Активен 16292
Tocilizumab EU/1/08/4 92/009 RoActemra, Solution for injection, 162, mg, Pack: 4 pre-filled pens Roche Registration GmbH, Германия Roche Pharma AG, Germany 1563.84 312.77 1876.61 4% 10 1573.84 314.77 1888.61 16% 25 1598.84 319.77 1918.61 НСР-16864/28.09.2018; НСР-20222/22.11.2019 Предварително изпълнение* 22.11.2019 02.12.2019 Неактивен 16292
Tocilizumab EU/1/08/4 92/009 RoActemra, Solution for injection, 162, mg, Pack: 4 pre-filled pens Roche Registration GmbH, Германия Roche Pharma AG, Germany 1647.81 329.56 1977.37 4% 10 1657.81 331.56 1989.37 16% 25 1682.81 336.56 2019.37 НСР-16864/28.09.2018 13.10.2018 02.11.2018 Неактивен 16292
Tocilizumab EU/1/08/4 92/009 RoActemra, Solution for injection, 162, mg, Pack: 4 pre-filled pens Roche Registration GmbH, Германия Roche Pharma AG, Germany 1647.81 329.56 1977.37 4% 10 1657.81 331.56 1989.37 16% 25 1682.81 336.56 2019.37 НСР-16864/28.09.2018 13.10.2018 02.11.2018 Неактивен 16292
Tocilizumab EU/1/08/492/003 RoActemra, Concentrate for solution for infusion, 20 mg/ml - 10 ml, mg, Pack: 1 Roche Registration GmbH, Германия Roche Pharma AG Germany 514.91 102.98 617.89 4% 10 524.91 104.98 629.89 16% 25 549.91 109.98 659.89 Промяна на обстоятелствата НСР-15987/22.06.2018. НСР-5077/21.11.2014; НСР-13342/28.07.2017 12.08.2017 02.08.2018 Активен 3377
Tocilizumab EU/1/08/492/003 RoActemra, Concentrate for solution for infusion, 20 mg/ml - 10 ml, mg, Pack: 1 Roche Registration GmbH, Германия Roche Pharma AG Germany 514.91 102.98 617.89 4% 10 524.91 104.98 629.89 16% 25 549.91 109.98 659.89 Промяна на обстоятелствата НСР-15987/22.06.2018. НСР-5077/21.11.2014; НСР-13342/28.07.2017 12.08.2017 02.08.2018 Неактивен 3377
Tocilizumab EU/1/08/492/005 RoActemra, Concentrate for solution for infusion, 20 mg/ml - 20 ml, mg, Pack: 1 Roche Registration GmbH, Германия Roche Pharma AG Germany 1029.82 205.96 1235.78 4% 10 1039.82 207.96 1247.78 16% 25 1064.82 212.96 1277.78 Промяна на обстоятелствата НСР-15986/22.06.2018. НСР-5078/21.11.2014; НСР-10019/18.08.2016; НСР-14455/17.11.2017 02.12.2017 02.08.2018 Активен 3378
Tocilizumab EU/1/08/492/005 RoActemra, Concentrate for solution for infusion, 20 mg/ml - 20 ml, mg, Pack: 1 Roche Registration GmbH, Германия Roche Pharma AG Germany 1029.82 205.96 1235.78 4% 10 1039.82 207.96 1247.78 16% 25 1064.82 212.96 1277.78 Промяна на обстоятелствата НСР-15986/22.06.2018. НСР-5078/21.11.2014; НСР-10019/18.08.2016; НСР-14455/17.11.2017 02.12.2017 02.08.2018 Неактивен 3378
Tocilizumab EU/1/08/492/001 RoActemra, Concentrate for solution for infusion, 20 mg/ml - 4 ml, mg, Pack: 1 Roche Registration GmbH, Германия Roche Pharma AG Germany 205.97 41.19 247.16 4% 8.24 214.21 42.84 257.05 16% 25 239.21 47.84 287.05 Промяна на обстоятелствата НСР-15983/22.06.2018. НСР-5076/21.11.2014; НСР-10018/18.08.2016; НСР-14456/17.11.2017 02.12.2017 02.08.2018 Активен 3376
Tocilizumab EU/1/08/492/001 RoActemra, Concentrate for solution for infusion, 20 mg/ml - 4 ml, mg, Pack: 1 Roche Registration GmbH, Германия Roche Pharma AG Germany 205.97 41.19 247.16 4% 8.24 214.21 42.84 257.05 16% 25 239.21 47.84 287.05 Промяна на обстоятелствата НСР-15983/22.06.2018. НСР-5076/21.11.2014; НСР-10018/18.08.2016; НСР-14456/17.11.2017 02.12.2017 02.08.2018 Неактивен 3376
Tocilizumab EU/1/08/492/001 RoActemra, Concentrate for solution for infusion, 20 mg/ml - 4 ml, mg, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG Germany 205.97 41.19 247.16 4% 8.24 214.21 42.84 257.05 16% 25 239.21 47.84 287.05 НСР-5076/21.11.2014; НСР-10018/18.08.2016; НСР-14456/17.11.2017 02.12.2017 02.01.2018 Неактивен 3376
Tocilizumab EU/1/08/492/005 RoActemra, Concentrate for solution for infusion, 20 mg/ml - 20 ml, mg, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG Germany 1029.82 205.96 1235.78 4% 10 1039.82 207.96 1247.78 16% 25 1064.82 212.96 1277.78 НСР-5078/21.11.2014; НСР-10019/18.08.2016; НСР-14455/17.11.2017 02.12.2017 02.01.2018 Неактивен 3378
Tocilizumab EU/1/08/492/003 RoActemra, Concentrate for solution for infusion, 20 mg/ml - 10 ml, mg, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG Germany 514.91 102.98 617.89 4% 10 524.91 104.98 629.89 16% 25 549.91 109.98 659.89 НСР-5077/21.11.2014; НСР-13342/28.07.2017 12.08.2017 02.09.2017 Неактивен 3377
Tocilizumab EU/1/08/492/001 RoActemra, Concentrate for solution for infusion, 20 mg/ml - 4 ml, mg, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG Germany 234.13 46.83 280.96 4% 9.37 243.5 48.7 292.2 16% 25 268.5 53.7 322.2 НСР-5076/21.11.2014; НСР-10018/18.08.2016 03.09.2016 02.10.2016 Неактивен 3376
Tocilizumab EU/1/08/492/005 RoActemra, Concentrate for solution for infusion, 20 mg/ml - 20 ml, mg, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG Germany 1146.76 229.35 1376.11 4% 10 1156.76 231.35 1388.11 16% 25 1181.76 236.35 1418.11 НСР-5078/21.11.2014; НСР-10019/18.08.2016 03.09.2016 02.10.2016 Неактивен 3378
Tocilizumab EU/1/08/492/003 RoActemra, Concentrate for solution for infusion, 20 mg/ml - 10 ml, mg, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG Germany 583.82 116.76 700.58 4% 10 593.82 118.76 712.58 16% 25 618.82 123.76 742.58 НСР-5077/21.11.2014 08.12.2014 08.12.2014 Неактивен 3377
Tocilizumab EU/1/08/492/001 RoActemra, Concentrate for solution for infusion, 20 mg/ml - 4 ml, mg, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG Germany 234.6 46.92 281.52 4% 9.38 243.98 48.8 292.78 16% 25 268.98 53.8 322.78 НСР-5076/21.11.2014 08.12.2014 08.12.2014 Неактивен 3376
Tocilizumab EU/1/08/492/005 RoActemra, Concentrate for solution for infusion, 20 mg/ml - 20 ml, mg, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG Germany 1151.79 230.36 1382.15 4% 10 1161.79 232.36 1394.15 16% 25 1186.79 237.36 1424.15 НСР-5078/21.11.2014 08.12.2014 08.12.2014 Неактивен 3378
Tocilizumab EU/1/08/492/005 RoActemra, Concentrate for solution for infusion, 20 mg/ml - 20 ml, mg, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG Germany 1179.27 235.85 1415.12 4% 10 1189.27 237.85 1427.12 16% 25 1214.27 242.85 1457.12 НСР-2939/07.03.2014 25.03.2014 25.03.2014 Неактивен 3378
Showing 13101 to 13126 of 17385 entries
Download link in CSV format: Copy
Download link in JSON format: Copy
Download link in XML format: Copy
 

Моля изчакайте